Rosaramicin (1), a 16-membered ring macrolide antibiotic, was isolated from the culture filtrate of Micromonospora rosaria'). The biosynthesis of rosaramicin was previously investigated3,3) and established the incorporation of radiolabeled acetic, propionic, and butyric acids and L-methionine into rosaramicin. However, we wished to explore the biosynthetic route of rosaramicin using intermediates and idiotrophs. Therefore, mutants blocked in rosaramicin biosynthesis were generated by the treatment of the rosaramicin producing strain M. rosaria (SCC 957, ATCC 29337) with NTG. Mutant T6071 was obtained which produced a mixture of two 16-membered lactones, 20-deoxorosaranolide (2) and 20-deoxo-12,13 -desepoxy -12,13 -dehydrorosaranolide (3). This paper describes the fermentation, isolation, and characterization of the two components.The aglycone complex, initially detected in test tube and 250 ml Erlenmeyer flask cultures, was produced in a 150-liter New Brunswick Scientific Fermentor containing 100 liters of a medium consisting of 1.5%. Amberex-1003, 0.3% fish peptone, 5 % potato dextrin, 0.2 % Pharmamedia (cotton seed flour), 1 % maltose, 0.02 % sodium thiosulfate, 0.001% cobalt chloride, 0.001 % manganese chloride, 0.1%. SAG-471 antifoam, and tap water. The pH of the medium was adjusted to 6.8 prior to sterilization. After inoculation, the culture was incubated at 30°C under aeration (57 liters/minute) with agitation (300 rpm) for 66 hours.The harvested fermentation broth (100 liters) was adjusted to pH 8.0 and extracted twice with 200-liter volumes of ethyl acetate. The ethyl acetate extracts were combined and concentrated under reduced pressure to give a crude residue. The residue was dissolved in 95 % aqueous ethanol and purified further on a column of Sephadex LH-20 (1,500 ml, Pharmacia Co.) using 95 % aqueous ethanol as the eluant at a flow rate of 1 ml/minute. Elution of the aglycone mixture occurred between 2 and 3 liters of eluant. Fractions were tested for the aglycone complex by thin-layer chromatography using Whatman 0.25 mm LK6DF silica gel plates developed for one hour in a solvent system of chloroform -methanol (9: 1, v/v) followed by treatment with sulfuric acid. Those fractions which contained compound with an Rf 0.7 were combined and concentrated to dryness. The residue was dissolved in a small volume of 95 % aqueous ethanol, water added, and the solution was lyophilized to yield 16 g of dry powder containing the rosaramicin aglycone complex.The complex was shown to be a mixture of components 2 and 3 in the ratio of 1: 4 based upon PMR, CMR, and MS data. Further purification by high performance liquid chromatography led to the separation of the complex into components 2 and 3 with greater than 95 purity. The complex was injected onto an E. S. Industries Chromegabond C-8 (10 it), 500 mm x 9.6 mm column and eluted with an acetonitrile -0.01 M ammonium acetate buffer (pH 4.0) (4: 6) mobile phase. Each injection of 80 mg of mixture yielded 13.8 mg of 2 and 42.2 mg of 3.The molecular formula of 2 was...
An actinomycete identified as a Dactylosporangium sp. produces a new tetracycline, 4a-hydroxy-8-methoxychlortetracycline (Sch 34164). The addition of magnesium ions to complex fermentation media increased the antibiotic titers. Sch 34164 was isolated by solvent extraction and Sephadex G-25 column chromatography. The novel structure was proposed based on spectroscopic analysis. The shift of C-4a (35 to 77 ppm) and C-8 (140 to 163 ppm) in the 13C NMRas compared to chlortetracycline was indicative of the novel hydroxyl and methoxysubstituents, respectively.An actinomycete, designated SCC1695, isolated from a sample collected in the Kasie Valley of Zambiawas found to produce in fermentation a newtetracycline antibiotic. The antibiotic was isolated from fermentation broth by solvent extraction and purified by Sephadex G-25 column chromatography. The producing strain was characterized and found to have the macroscopic, microscopic and whole-cell hydrolysis properties of the genus Dactylosporangium.This paper describes the production, isolation, physico-chemical properties and structure elucidation of Sch 341641}. Taxonomy and biological properties2) will be reported elsewhere. FermentationThe fermentation studies were carried out in shake flasks and 14-liter fermentors. An aliquot of the frozen whole broth was used to inoculate a germination medium composed of Cerelose 0.1 %, potato starch 2.4%, beef extract 0.3%, yeast extract 0.5% Tryptone 0.5% and CaCO3 0.2%. The pH of the mediumwas adjusted to 7.0 prior to sterilization. The seed culture was incubated at 30°Con a rotary shaker at 300 rpm for 48 hours. Twenty five ml of the resulting seed culture were transferred to a 2-liter Erlenmeyer flask containing 500 ml of the above mediumand incubated for an additional 48 hours at 30°C. The entire content was used to inoculate a 14-liter fermentor containing 10 liters of the production medium consisting of Cerelose 1.0 %>soluble starch 2 %, yeast extract 0.5 %, NZ-Amine 0.5%, CaCO3 0.4% and 1 mMCoCl2 1 ml. The fermentation was carried out at 30°C, 300rpm and aeration of 3.5 liters per minute for 96 hours.Antibiotic production in shake flasks and tanks was monitored at 72 and 96 hours by whole broth disc-agar diffusion assay against Staphylococcus aureus and Escherichia coli. Since the initial titers were extremely low, experiments in shake flasks focusing on the production mediumwere initiated to increase antibiotic titers. The fermentation mediumdiscussed previously was supplemented with various ions at the concentration shown in Table 1. All ionic solutions were added post steriliza-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.